恩替卡韦
医学
慢性肝炎
多中心研究
内科学
甲型肝炎病毒
临床试验
多中心试验
重症监护医学
胃肠病学
病毒学
随机对照试验
病毒
拉米夫定
作者
Mingyuan Zhang,Yanhang Gao,Fei Kong,Haibing Gao,Yongxiang Yi,Chao Wu,Yongning Xin,Sujun Zheng,Jiajie Lu,Tao Han,Yingren Zhao,Peng Hu,Xiaorong Mao,Qing Xie,Mingjie Zhang,Jinlin Hou,Zhiliang Gao,Jianqi Lian,Liang Chen,Jia Shang
标识
DOI：10.1016/j.jinf.2025.106446
摘要
The primary analysis at week 48 showed that the antiviral efficacy of GLS4/RTV with ETV was clearly superior to that of ETV monotherapy. GLS4/RTV with ETV was well tolerated; further studies evaluating its safety and efficacy are ongoing. (clinical trial identifier: NCT04147208).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
dde
cdercder
无极微光
AllRightReserved
嘻嘻哈哈
Moonpie
Nexus
Twonej
糊涂的雅琴
arniu2008
ww2026
科研狗
OK
殷勤的紫槐
HFH
乐空思
Scorpia112
贪玩的秋柔
GingerF
仰望喀纳斯的星空
皖公网安备34019202002308
